1. Home
  2. B17 - Testimonials
  3. Bud Robinson – Phoenix, Arizona

Bud Robinson – Phoenix, Arizona

The following letter from Bud Robinson in Phoenix, Arizona, needs no further comment. It was sent to Dr. Ernest Krebs Jr.

Dear Dr. Krebs,
Thank you for giving me another birthday (May 17). Please, again, remember November 15, 1979, when my doctor and four other urologists gave me a maximum of four months to live with my prostate cancer, and they set up appointments for radiation and chemotherapy, which I knew would kill me if the cancer didn’t, and refused their treatment.

Then on a Sunday afternoon I contacted you by telephone and went with your simple program.

I am 71 years old and am on my 13th year [of survival]. Three of the four urologists have died with prostate cancer, and forty or fifty people are alive today, and doing well, because they followed my “Krebs” simple program.

Thanks again for giving me back my life.

Your friend,H.M. “Bud” Robinson “

This letter was written in 1992. When the author contacted him in June of 1996, Mr. Robinson was still going strong. His age at that time was 75, not 71, and the number of cancer patients he had helped to recover was up to 90.

The use of Amygdalin in the treatment of cancer is not new. The earliest recorded case was published in 1845 in the Paris Medical Gazzette. A young cancer patient was given 46,000 milligrams of Amygdalin over a period of several months in 1842 and, reportedly, was still living at the time of the article three years later. A woman with extensive cancer throughout her body received varying amounts of amygdalin starting in 1834 and was still surviving at the time of the report eleven years later.

Since the publication of this report, there have been literally thousands of similar case histories reported and documented. It is important to know that because, as demonstrated previously, spokesmen for orthodox medicine have stated authoritatively that there simply is no evidence that Laetrile works. The truth is that the evidence is everywhere.

When confronted with this evidence, some doctors, because of their professional bias against nutritional medicine, seek alternative explanations. Their favorite is that the cancer had a delayed response to previous treatment. But such cases are rare. With certain cancer locations — such as testicular chorionepithelioma, for example — they are so rare as to defy statistical analysis. And when one comes up with a series of such cases, all of which involve proven cancers, and all of which have responded to B17, it is beyond reason to speak of spontaneous regressions.

In a banquet speech in San Francisco on November 19, 1967, Dr. Krebs reviewed six such cases. then he added:

“Now there is an advantage in not having had prior radiation, because if you have not received prior radiation that has failed, then you cannot enjoy the imagined benefits of the delayed effects of prior radiation. So this boy falls into the category of “spontaneous regression….”

And when we look at this scientifically, we know that spontaneous regression occurs in fewer than one in 150,000 cases of cancer. The statistical possibilities of spontaneous regression accounting for the complete resolution of six successive cases of testicular chorionepithelioma is far greater than the improbability of the sun not rising tomorrow morning.

With the passage of each year and the presence of a growing steam of patients who are living proof of their claim, it becomes increasingly difficult to ignore or dismiss these recoveries. If they are spontaneous remissions, then, indeed, it must be said in all fairness that Laetrile produces far more spontaneous remissions than all other forms of therapy put together.


Updated on May 31, 2023

Was this article helpful?

Related Articles

Leave a Comment